EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Iron metabolism dysfunction in neuropsychiatric disorders: Implications for therapeutic intervention

Eduardo Duarte-Silva, Michael Maes, Christina Alves Peixoto

Behavioural Brain Research · 2025-02 · 479 · 115343

DOI: 10.1016/j.bbr.2024.115343 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Behavioural Brain Research, 2025-02. Verfasst von Eduardo Duarte-Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, Department of Pharmacology, University of São Paulo, São Paulo, B…. Hauptthemen laut MEDLINE: Iron. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 136 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron is a trace metal that takes part in the maintenance of body homeostasis by, for instance, aiding in energy production and immunity. A body of evidence now demonstrates that dysfunction in iron metabolism can have detrimental effects and is intricately associated with the development of neuropsychiatric disorders, including Major Depressive Disorder (MDD), anxiety, and schizophrenia. For instance, changes in serum and central nervous system (CNS) levels of iron and in proteins mediating iron metabolism have been documented in patients grappling with the aforementioned diseases. By contrast, targeting iron metabolism by using iron chelators, for instance, has proven to be effective in alleviating disease burden. Therefore, here we review the state-of-the-art regarding the role of iron metabolism and its dysfunction in the context of neuropsychiatric disorders. Furthermore, we discuss how targeting iron metabolism can be an effective therapeutic option to tackle this class of diseases. Finally, we discuss the mechanisms linking this dysfunction to behavioral changes in these disorders. Harnessing the knowledge of iron metabolism is not only key to the characterization of novel molecular targets and disease biomarkers but also crucial to drug repurposing and drug design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IronHumansAnimalsSchizophreniaMajor Depressive DisorderIron Chelating AgentsMental Disorders

Stichwörter der Autor:innen

Anxiety disordersBipolar disorderIronIron metabolismMajor depressive disorder (MDD)Neurodevelopmental disorders

Substanzen

IronIron Chelating Agents

Autor:innen und Institutionen

  • Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, Department of Pharmacology, University of São Paulo, São Paulo, Brazil; Network of Immunity in Infection, Malignancy and Autoimmunity (…
  • Mental Health Center, University of Electronic Science and Technology of China, Chengdu 611731, China; Deakin University, IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine…
  • Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), PE, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeir…

Zitieren

APA

Duarte-Silva, E., Maes, M., & Alves Peixoto, C. (2025). Iron metabolism dysfunction in neuropsychiatric disorders: Implications for therapeutic intervention. Behavioural Brain Research, 479, 115343. https://doi.org/10.1016/j.bbr.2024.115343

Vancouver

Duarte-Silva E, Maes M, Alves Peixoto C. Iron metabolism dysfunction in neuropsychiatric disorders: Implications for therapeutic intervention. Behavioural Brain Research. 2025;479:115343. doi:10.1016/j.bbr.2024.115343

BibTeX
@article{DuarteSilva2025,
  author = {Duarte-Silva, Eduardo and Maes, Michael and Alves Peixoto, Christina},
  title = {Iron metabolism dysfunction in neuropsychiatric disorders: Implications for therapeutic intervention},
  journal = {Behavioural Brain Research},
  year = {2025},
  volume = {479},
  pages = {115343},
  doi = {10.1016/j.bbr.2024.115343}
}
Kostenlos starten →